Wider Indications Will Give Edge to Plavix AGs: Nichi-Iko Pres.

May 14, 2015
Nichi-Iko President Yuichi Tamura The president of Nichi-Iko Pharmaceutical has voiced his confidence about authorized generic (AG) versions of Sanofi’s blockbuster antiplatelet Plavix (clopidogrel) the company plans to launch in June, saying that they will gain the upper hand over...read more